Novartis Corporation (NVS) Release: 8 Scottish Life Science Companies Descend Upon Boston in Search of Investors and Partners
6/15/2012 9:57:10 AM
More...
|
Novartis Corporation (NVS) Sits in the Penalty Box
4/25/2012 8:07:17 AM
More...
|
FDA Approves Novartis Corporation (NVS)'s Gleevec for Expanded Use in Patients With Rare Gastrointestinal Cancer
2/1/2012 6:44:03 AM
More...
|
Endo Pharmaceuticals (ENDP) Announces Potential Short-Term Supply Constraints of Certain Analgesic Medications as a Result of Temporary Shut Down of Novartis Corporation (NVS)Facility
1/9/2012 11:51:10 AM
More...
|
Novartis Corporation (NVS) Pivotal Study of Exjade(R) Shows Significant Reduction of Iron Overload in Patients with Non-transfusion-dependent Thalassemia
12/13/2011 11:39:43 AM
More...
|
Novartis Corporation (NVS) Phase III Study Shows ACZ885 Helped Substantially Reduce Steroid Use in 45% of Patients With Serious Form of Childhood Arthritis
11/7/2011 11:40:52 AM
More...
|
Viamet Pharmaceuticals Appoints Former Novartis Corporation (NVS) Executive Marc Rudoltz, M.D. as Chief Medical Officer
11/3/2011 9:17:37 AM
More...
|
Novartis Corporation (NVS) Release: IBM Corporation (IBM) Launches University Competition to Combat Growth of Non-Communicable Diseases
10/10/2011 6:01:01 AM
More...
|
Novartis AG (NVS) Receives Approval in Japan for Two Innovative Therapies, Gilenya(R) in MS and Ilaris(R) in CAPS
9/27/2011 7:43:31 AM
More...
|
Novartis Corporation (NVS) Associates Participate in First Company-Wide Health and Well-Being Initiative
9/19/2011 11:00:34 AM
More...
|
|